Acetyl-L-carnitine for patients with hepatic encephalopathy
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the clinical benefits and harms of acetyl-L-carnitine for treating patients with hepatic encephalopathy
- Autores:
-
Arévalo Rodríguez, Ingrid
Martí Carvajal, AJ
Gluud, C
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2014
- Institución:
- Fundación Universitaria de Ciencias de la Salud - FUCS
- Repositorio:
- Repositorio Digital Institucional ReDi
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.fucsalud.edu.co:001/2688
- Acceso en línea:
- https://repositorio.fucsalud.edu.co/handle/001/2688
- Palabra clave:
- Acetylcarnitine
Hepatic Encephalopathy
Patients
Acetilcarnitina
Encefalopatía hepática
Paciente
- Rights
- openAccess
- License
- Atribución-NoComercial-SinDerivadas 4.0 Internacional (CC BY-NC-ND 4.0)
| Summary: | This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the clinical benefits and harms of acetyl-L-carnitine for treating patients with hepatic encephalopathy |
|---|